ERBB2 and cancer: Heterogeneity of HER2 expression in cancer has been recognized as a major challenge, and a plethora of studies have demonstrated the spatial and temporal heterogeneity of HER2 expression and its impact on treatment outcomes [3,12,13,14,15].